AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 18c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q2 EPS of ($1.34), $0.18 better than the analyst estimate of ($1.52). Revenue for the quarter came in at $22.26 million versus the consensus estimate of $11.51 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Antero Resources (AR) PT Raised to $47 at Benchmark on Natural Gas Bull Case
• KeyBanc Reiterates Overweight Rating on Magnolia Oil & Gas Corp. (MGY)
• CAVA Group Inc (CAVA) PT Lowered to $95 at KeyBanc